OBJECTIVE: To investigate antiretroviral treatment (ART) interruption in a long-term treatment cohort in South Africa. METHODS: All adults accessing ART between 2004 and 2009 were included in this analysis. Defaulting was defined as having stopped all ART drugs for more than 30 days. Treatment interrupters were patients who defaulted and returned to care during the study, whereas loss to follow-up was defined as defaulting and not returning to care. Kaplan-Meier estimates and Poisson regression models were used to analyze rates and determinants of defaulting therapy and of treatment resumption. RESULTS: Overall rate of defaulting treatment was 12.8 per 100 person-years (95% confidence interval: 11.4 to 14.4). Risk factors for defaulting wer...
Background: Treatment interruption and switch to a new Highly Active Antiretroviral Therapy (HAART) ...
This is an open access article distributed under the terms of the Creative Commons Attribution Licen...
Abstract Background Achieving optimal adherence to highly active antiretroviral therapy (HAART) is n...
OBJECTIVE: To determine rates of, and factors associated with, disengagement from care in a decentra...
Objective: We aimed to investigate potential causes of higher risk of treatment interruptions within...
Introduction A recent systematic review estimated that almost a quarter of patients in low- and midd...
Background: Unplanned care interruption (UCI) challenges effective HIV treatment. We determined the ...
Objective This study described the demographics, treatment information and identified characteristic...
Includes bibliographical referencesOver the past decade, antiretroviral therapy (ART) programmes hav...
The prognosis of patients with HIV in Africa has improved with the widespread use of antiretroviral ...
Background Retention in care is an essential component of meeting the UNAIDS “90-90-90” HIV treatmen...
BACKGROUND: Loss to follow-up (LTF) challenges the reporting of antiretroviral treatment (ART) progr...
Introduction: Little is known about the impact of antiretroviral therapy (ART) guideline changes on ...
South Africa has undergone multiple expansions in antiretroviral therapy (ART) eligibility from an i...
<p><b>(a) Cumulative incidence (competing risks analysis) of disengagement, transfer (including sile...
Background: Treatment interruption and switch to a new Highly Active Antiretroviral Therapy (HAART) ...
This is an open access article distributed under the terms of the Creative Commons Attribution Licen...
Abstract Background Achieving optimal adherence to highly active antiretroviral therapy (HAART) is n...
OBJECTIVE: To determine rates of, and factors associated with, disengagement from care in a decentra...
Objective: We aimed to investigate potential causes of higher risk of treatment interruptions within...
Introduction A recent systematic review estimated that almost a quarter of patients in low- and midd...
Background: Unplanned care interruption (UCI) challenges effective HIV treatment. We determined the ...
Objective This study described the demographics, treatment information and identified characteristic...
Includes bibliographical referencesOver the past decade, antiretroviral therapy (ART) programmes hav...
The prognosis of patients with HIV in Africa has improved with the widespread use of antiretroviral ...
Background Retention in care is an essential component of meeting the UNAIDS “90-90-90” HIV treatmen...
BACKGROUND: Loss to follow-up (LTF) challenges the reporting of antiretroviral treatment (ART) progr...
Introduction: Little is known about the impact of antiretroviral therapy (ART) guideline changes on ...
South Africa has undergone multiple expansions in antiretroviral therapy (ART) eligibility from an i...
<p><b>(a) Cumulative incidence (competing risks analysis) of disengagement, transfer (including sile...
Background: Treatment interruption and switch to a new Highly Active Antiretroviral Therapy (HAART) ...
This is an open access article distributed under the terms of the Creative Commons Attribution Licen...
Abstract Background Achieving optimal adherence to highly active antiretroviral therapy (HAART) is n...